raloxifene hydrochloride has been researched along with Obesity in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gozansky, WS; Jankowski, CM; Kittelson, JM; Kohrt, WM; Schwartz, RS; Van Pelt, RE; Wolfe, P | 1 |
| Aliaga, C; Calcagnotto, A; Demers, LM; DuBrock, C; El-Bayoumy, K; Hamilton, C; Hartman, TJ; Liao, J; Manni, A; McGinley, J; Prokopczyk, B; Richie, JP; Sandhu, N; Schetter, SE; Signori, C; Thompson, HJ; Trushin, N | 1 |
| Olver, IN | 1 |
| Aliaga, C; Calcagnotto, A; El-Bayoumy, K; Manni, A; Richie, JP; Schetter, SE; Trushin, N | 1 |
| Lovre, D; Mauvais-Jarvis, F; Xu, B | 1 |
| Cauley, JA; Cecchini, RS; Costantino, JP; Cronin, WM; Land, SR; Weissfeld, JL; Wickerham, DL; Wolmark, N | 1 |
| Kafka, A; Kreienberg, R | 1 |
| Barrett-Connor, E; Blackwell, T; Davidowitz, N; Kanaya, AM; Krueger, K; Yaffe, K | 1 |
| Fajardo, ME; Malacara, JM; Nava, LE | 1 |
2 review(s) available for raloxifene hydrochloride and Obesity
| Article | Year |
|---|---|
Prevention of breast cancer.
Topics: Alcohol Drinking; Australia; Breast Neoplasms; Female; Genes, BRCA1; Genetic Testing; Hormone Replacement Therapy; Humans; Life Style; Mammography; Mastectomy; Obesity; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Tamoxifen; Tobacco Use | 2016 |
The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.
Topics: Aging; Animals; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Humans; Indoles; Insulin Resistance; Models, Biological; Obesity; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2017 |
4 trial(s) available for raloxifene hydrochloride and Obesity
| Article | Year |
|---|---|
Estrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes.
Topics: Adiposity; Aged; Blood Glucose; Body Composition; Energy Metabolism; Estrogen Replacement Therapy; Estrogens; Exercise; Female; Humans; Insulin; Lipids; Middle Aged; Obesity; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome; Weight Loss | 2014 |
Influence of Obesity on Breast Density Reduction by Omega-3 Fatty Acids: Evidence from a Randomized Clinical Trial.
Topics: Adult; Aged; Body Mass Index; Breast; Breast Density; Breast Neoplasms; Docosahexaenoic Acids; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Obesity; Raloxifene Hydrochloride; Tamoxifen | 2016 |
Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women.
Topics: Adult; Aged; Biomarkers; Body Mass Index; Breast Density; Breast Neoplasms; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Estrogen Receptor Modulators; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Omega-3; Female; Follow-Up Studies; Humans; Middle Aged; Obesity; Oleic Acid; Palmitic Acid; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Stearoyl-CoA Desaturase | 2017 |
Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens.
Topics: Chromans; Clomiphene; Estrogens; Feedback, Physiological; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Hypoglycemic Agents; Insulin Resistance; Menopause; Metformin; Middle Aged; Obesity; Pregnancy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
3 other study(ies) available for raloxifene hydrochloride and Obesity
| Article | Year |
|---|---|
Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.
Topics: Adult; Aged; Body Mass Index; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Invasiveness; Obesity; Postmenopause; Premenopause; Proportional Hazards Models; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Tamoxifen | 2012 |
[From alcohol abstinence to total surgery. Preventive strategies in breast carcinoma].
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Dietary Fats; Estradiol; Estrogen Antagonists; Ethanol; Follow-Up Studies; Humans; Incidence; Insulin-Like Growth Factor I; Mastectomy; Middle Aged; Obesity; Osteoporosis; Ovariectomy; Placebos; Postmenopause; Primary Prevention; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Sports; Tamoxifen; Time Factors | 2003 |
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women.
Topics: Age Factors; Aged; Blood Glucose; Brain; Cardiovascular Diseases; Cognition Disorders; Comorbidity; Dementia; Depression; Diabetes Mellitus; Fasting; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Middle Aged; Obesity; Odds Ratio; Osteoporosis, Postmenopausal; Prediabetic State; Psychological Tests; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Tomography, X-Ray Computed | 2004 |